Positive Results From CardioKinetix’s Parachute Device Clinical Trial on Ischemic Heart Failure

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced clinical results showing meaningful and sustained low clinical events for patients with ischemic heart failure three years following Percutaneous Ventricular Restoration (PVR) therapy with the first-of-its-kind catheter-based Parachute Ventricular Partitioning Device.   
News-Medical.net